Therapeutic Action
Potassium supplement, when immediate effect is required
PDF page 257
Loading InternPractice…
Drug reference
Potassium supplement, when immediate effect is required
PDF page 257
Treatment of moderate hypokalaemia
PDF page 257
Reduce dosage in older patients and patients with renal impairment (risk of hyperkalaemia). Do not combine with spironolactone and angiotensin-converting-enzyme inhibitors (e.g. enalapril). May cause: gastrointestinal ulcerations, diarrhoea, nausea and vomiting, rarely hyperkalaemia. Administer with caution to patients with gastrointestinal ulcer (risk of gastrointestinal ulcerations). Pregnancy: no contra-indication Breast-feeding: no contra-indication
PDF page 258
+ 7.5% potassium chloride syrup (1 mmol of K /ml), to be administered using a measuring device (oral syringe, mesuring spoon, or cup with graduations)
PDF page 257
Child under 45 kg: 2 mmol/kg (2 ml/kg) daily (see table below) Child 45 kg and over and adult: 30 mmol (30 ml) 3 times daily Age Weight 7.5% syrup < 2 months < 5 kg 4 ml x 2 2 months to < 1 year 5 to < 10 kg 6 ml x 2 1 to < 3 years 10 to < 15 kg 12 ml x 2 3 to < 5 years 15 to < 20 kg 20 ml x 2 5 to < 7 years 20 to < 25 kg 25 ml x 2 7 to < 9 years 25 to < 30 kg 20 ml x 3 9 to < 13 years 30 to < 45 kg 25 ml x 3 ≥ 13 years and adult ≥ 45 kg 30 ml x 3
PDF pages 257, 258
According to clinical response. Treatment of 1 to 2 days is typically sufficient when the patient is fully able to drink oral rehydration solution and can eat.
PDF page 258
Take with or at the end meals in order to reduce the risk of gastrointestinal ulcerations. Hypokalaemia is defined as a serum potassium concentration below 3.5 mmol/litre.
PDF page 258
Below 25 °C
PDF page 258
2 mmol/kg (2 ml/kg) daily (see table below)
PDF page 257
30 mmol (30 ml) 3 times daily
PDF page 257